Earnings Call · Q2 FY2024·2024-08-07

Q2 24EPS +30.77%·Rev n/aQ1 24EPS +30.77%·Rev n/aQ4 23EPS +28.57%·Rev n/aQ3 23EPS -10.00%·Rev n/a⚠ consensus missing

MAXCYTE, INC. MXCT

Scott Feinberg — Finance and Investor Relations Associate

Maher Masoud — President and Chief Executive Officer

Doug Swirsky — Chief Financial Officer

+2.5%1d on move date+1.6% vs SPY3d−3.7%5d−7.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MXCT calls or request research access.

More MXCT calls Browse calls Request research access